Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · GE HealthCare (GEHC)

GE HealthCare Q4 EPS rises to $1.57 from $0.88; 2025 adjusted EPS guided $4.61-$4.75

Positive Impact 3 of 5 earnings Written later

GE HealthCare reported fourth-quarter 2024 revenue of $5.3 billion, up 2% year over year, and diluted EPS of $1.57 versus $0.88 a year earlier. For full-year 2024, revenue was $19.7 billion, up 1%, and adjusted EPS was $4.49 versus $3.93. The company also introduced 2025 guidance calling for adjusted EPS of $4.61 to $4.75, which it says represents 3% to 6% growth.

Key points

  • Q4 2024 revenue was $5.3 billion, up 2%; net income attributable to GE HealthCare was $720 million versus $403 million
  • Q4 2024 adjusted EPS was $1.45 versus $1.18; full-year 2024 adjusted EPS was $4.49 versus $3.93
  • 2025 guidance: organic revenue growth of 2% to 3%, adjusted EBIT margin of 16.7% to 16.8%, and free cash flow of at least $1.75 billion
  • Full-year 2024 free cash flow was $1.6 billion, down $161 million year over year

The filing

CompanyGE HealthCare (GEHC)
Form8-K, current report
Filed with the SECFeb 13, 2025, 6:25 AM ET
Accession number0001932393-25-000004

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:30 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 13, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.